Treatment of experimental staphylococcal osteomyelitis with rifampin and trimethoprim, alone and in combination
Open Access
- 1 April 1980
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 17 (4) , 591-594
- https://doi.org/10.1128/aac.17.4.591
Abstract
Rifampin and trimethoprim were used alone and in combination in the treatment of chronic osteomyelitis due to Staphylococcus aureus in rabbits. Rifampicin levels in infected bone were well above the minimum inhibitory concentration of the infecting strain of S. aureus for at least 4 h after injection. In contrast, trimethoprim levels in diseased bone were below the minimum inhibitory concentration as early as 1 h after injection. Trimethoprim or rifampin, administered alone for 14 days, were ineffective in sterilizing infected rabbit bones. The combination of rifampin plus trimethoprim was significantly more effective (P less than 0.005) than either agents given alone for a comparable duration of time. Staphylococci isolated from the bones of rabbits treated with rifampin alone or rifampin plus trimethoprim were uniformly resistant to rifampin, but retained their susceptibility to trimethoprim.This publication has 8 references indexed in Scilit:
- Experimental Osteomyelitis Caused by Pseudomonas aeruginosaThe Journal of Infectious Diseases, 1980
- Interaction between rifampicin and trimethoprimJournal of Antimicrobial Chemotherapy, 1979
- Antagonistic interaction of rifampicin and trimethoprimJournal of Antimicrobial Chemotherapy, 1978
- Experimental Osteomyelitis. V. Therapeutic Trials with Oxacillin and Sisomicin Alone and in CombinationThe Journal of Infectious Diseases, 1978
- Experimental Osteomyelitis. IV. Therapeutic Trials with Rifampin Alone and in Combination with Gentamicin, Sisomicin, and CephalothinThe Journal of Infectious Diseases, 1975
- Experimental Osteomyelitis. I. A Description of the ModelThe Journal of Infectious Diseases, 1970
- Antituberculous activity of rifampin in vitro and in vivo and the concentrations attained in human blood.Published by Elsevier ,1968
- TRIMETHOPRIM, A SULPHONAMIDE POTENTIATORBritish Journal of Pharmacology, 1968